Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)Application
Figure 2:Immunohistochemical analysis of paraffin-embedded bladder cancer tissues using NAPSA mouse mAb with DAB staining.| Product Name | NAPSA |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | KAP; Kdap; NAP1; NAPA; SNAPA |
| Immunogen | Synthesized peptide of human NAPSA (AA: KPIFVPLSNYRDVQYc). |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | IHCICC/IF |
| IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Alternative Names | KAP Kdap NAP1 NAPA SNAPA |
|---|---|
| Molecular Weight(MW) | 45.4kDa |
| Entrez Gene | 9476 |
|---|
Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Application
Figure 2:Immunohistochemical analysis of paraffin-embedded bladder cancer tissues using NAPSA mouse mAb with DAB staining.| Application Notes | IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Purified antibody in PBS with 0.05% sodium azide |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
